4-methylhistamine has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, WK; He, GH; Hu, J; Li, T; Ma, X; Meng, JR; Xu, GL; Yin, SJ; Zhao, CH | 1 |
1 other study(ies) available for 4-methylhistamine and Lung Neoplasms
| Article | Year |
|---|---|
Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Topics: Animals; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclic AMP; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Immunohistochemistry; Indoles; Lung Neoplasms; Methylhistamines; Mice; Mice, Nude; Piperazines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Snail Family Transcription Factors; Survival Analysis; Transcription Factors; Transforming Growth Factor beta1; Vimentin; Xenograft Model Antitumor Assays; Zinc Finger E-box-Binding Homeobox 1 | 2014 |